{{Rsnum
|rsid=80358238
|Chromosome=1
|Orientation=plus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=FASLG
|position=172665636
|Gene_s=FASLG
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ClinVar
|rsid=80358238
|Reversed=0
|FwdREF=A
|FwdALT=G
|REF=A
|ALT=G
|RSPOS=172665636
|CHROM=1
|dbSNPBuildID=137
|SSR=0
|SAO=1
|VP=0x050368000a05000002110100
|GENEINFO=FASLG:356
|GENE_NAME=FASLG
|GENE_ID=356
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.11:g.172665636A>G
|CLNSRC=ClinVar; GeneReviews
|CLNORIGIN=0
|CLNSRCID=NM_000639.1:c.466A>G; NBK1108
|CLNSIG=5
|CLNCUI=C1328840
|CLNDBN=Autoimmune lymphoproliferative syndrome
|Disease=Autoimmune lymphoproliferative syndrome
|CLNACC=RCV000020369.2
|Tags=PM;PMC;S3D;SLO;NSM;REF;ASP;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1108:C1328840:601859:ORPHA3261
}}{{PMID Auto
|PMID=17605793
|Title=Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
|OA=1
}}